Related Experiment Videos
Neonatal screening and an intensive management programme for galactosaemia: early evidence of benefits
A Hayes1, F G Bowling, D Fraser
1Schonell Special Education Research Centre, University of Queensland, St Lucia.
Insights
Neonatal screening and early management of galactosaemia in children show promising results. Children identified through screening appear to develop normally, unlike those diagnosed before screening, suggesting improved long-term outcomes.
Area of Science:
- Metabolic disorders
- Pediatric medicine
- Genetics
Background:
- Galactosaemia is a rare genetic metabolic disorder.
- Early diagnosis and management are crucial for improving patient outcomes.
- Neonatal screening programs aim to detect conditions like galactosaemia early.
Purpose of the Study:
- To evaluate the impact of neonatal screening on children with galactosaemia.
- To compare developmental outcomes between pre-screening and screening-identified groups.
- To assess the effectiveness of a multiprofessional management program.
Main Methods:
- Prospective study of children with galactosaemia.
- Collection of biochemical, clinical, dietary, developmental, and speech/language data.
- Comparison of two groups: pre-screening diagnosis vs. screening identification.
Main Results:
- Pre-screening group (diagnosed before 1982) showed low-average to moderate intellectual disability and speech/language issues.
- Screening group (identified via neonatal screening) are developing normally in infancy/early childhood, with one exception.
- One child in the screening group exhibits speech and language difficulties.
Conclusions:
- Neonatal screening for galactosaemia appears to lead to better developmental outcomes.
- Multiprofessional management is key to improving the prognosis for affected children.
- Early detection through screening offers cautious optimism for improved long-term health in galactosaemia patients.
Abstract:
A prospective study of children with galactosaemia is being undertaken at the Metabolic Clinic, Royal Children's Hospital, Brisbane. The purpose of the study is to collect biochemical, clinical, dietary, developmental and speech and language data. This paper describes the operation of the multiprofessional management programme and reports results for two groups of children: those who were diagnosed before the introduction of neonatal screening in 1982 (the prescreening group) and those who were identified by screening. The eight children in the prescreening group have shown intellectual development in the low-average to moderately-handicapped range. Most of them have speech and language difficulties. The screening group, all of whom are still in infancy or early childhood, appears to be developing normally, with the exception of one child who is showing problems with speech and language. The early results provide a basis for cautious optimism that neonatal screening and careful management will result in improved outcomes for children with galactosaemia.